Anavex Life Sciences Corp - Company Profile
Powered by
All the data and insights you need on Anavex Life Sciences Corp in one report.
- Save hours of research time and resources with
our up-to-date Anavex Life Sciences Corp Strategy Report
- Understand Anavex Life Sciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Anavex Life Sciences Corp Catalyst Calendar
Proactively evaluate Anavex Life Sciences Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Anavex Life Sciences Corp Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
30 Sep 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Jun 2020 | Phase II Trial Results | Anavex Life Sciences Corp; International Rett Syndrome Foundation; Leon Research SL; Michael J Fox Foundation for Parkinson's Research | AVXL | blarcamesine hydrochloride | Central Nervous System | Cognitive Impairment; Dementia; Parkinson's Disease; Sleep Disorders | Company Press Release |
01 Jun 2020 | Phase I Trial Initiation | Anavex Life Sciences Corp; CMAX Clinical Research Pty Ltd | AVXL | ANAVEX-371 | Central Nervous System | Alzheimer's Disease; Parkinson's Disease; Pick Disease | Clinical Trial Registry |
01 Mar 2020 | Phase II/III Trial Initiation | Anavex Life Sciences Corp | AVXL | blarcamesine hydrochloride | Central Nervous System | Rett Syndrome | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer